PharmGKB Blog
Tuesday, June 17, 2014

CPIC simvastatin & SLCO1B1 guideline 2014 update published

›
The 2014 update of CPIC guideline regarding SLCO1B1 and simvastatin-induced myopathy , has been published in Clinical Pharmacology and Thera...
Thursday, June 12, 2014

New publication: PharmGKB Uric acid-lowering drugs pathway

›
Disorders involving uric acid levels are prevalent (e.g. gout, hyperuricemia and resultant kidney failure) and pharmaceuticals that reduce t...
Saturday, June 7, 2014

Big Data Conference Videos

›
Videos of the talks at the Stanford Big Data Conference 2014 are now available to watch online ( view agenda ) . A selection of our favor...

New publication: NAT2 VIP Summary

›
The PharmGKB Very Important Pharmacogene (VIP) summary for NAT2 has been published in Pharmacogenetics & Genomics.   ...
Wednesday, May 28, 2014

Tramadol pathway summary published in PG&G

›
Tramadol is a centrally acting opioid analgesic used to relieve moderate to severe pain.  It is administered as a racemic mixture of (+) ...
Wednesday, May 21, 2014

Big Data Conference 2014

›
Stanford University are hosting the second Big Data in Biomedicine conference this week, featuring speakers across academia, industry and g...
Monday, May 12, 2014

Update: CPIC ivacaftor-CFTR guideline

›
The CPIC guideline for ivacaftor treatment based on CFTR genotype has been updated on PharmGKB, in light of changes to the FDA-approved dru...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.